NO20000934D0 - Adipocyttspesifikke proteinhomologer - Google Patents
Adipocyttspesifikke proteinhomologerInfo
- Publication number
- NO20000934D0 NO20000934D0 NO20000934A NO20000934A NO20000934D0 NO 20000934 D0 NO20000934 D0 NO 20000934D0 NO 20000934 A NO20000934 A NO 20000934A NO 20000934 A NO20000934 A NO 20000934A NO 20000934 D0 NO20000934 D0 NO 20000934D0
- Authority
- NO
- Norway
- Prior art keywords
- adipocyte
- specific protein
- protein homologs
- zsig39
- polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5698397P | 1997-08-26 | 1997-08-26 | |
PCT/US1998/017724 WO1999010492A1 (en) | 1997-08-26 | 1998-08-26 | Adipocyte-specific protein homologs |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20000934D0 true NO20000934D0 (no) | 2000-02-25 |
NO20000934L NO20000934L (no) | 2000-04-26 |
Family
ID=22007782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20000934A NO20000934L (no) | 1997-08-26 | 2000-02-25 | Adipocyttspesifikke proteinhomologer |
Country Status (11)
Country | Link |
---|---|
US (3) | US6197930B1 (no) |
EP (1) | EP1009829B1 (no) |
JP (1) | JP3492999B2 (no) |
KR (1) | KR20010023325A (no) |
CN (1) | CN1272884A (no) |
AT (1) | ATE324443T1 (no) |
AU (1) | AU744254B2 (no) |
CA (1) | CA2301660A1 (no) |
DE (1) | DE69834334T2 (no) |
NO (1) | NO20000934L (no) |
WO (1) | WO1999010492A1 (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6469158B1 (en) * | 1992-05-14 | 2002-10-22 | Ribozyme Pharmaceuticals, Incorporated | Synthesis, deprotection, analysis and purification of RNA and ribozymes |
US6642360B2 (en) * | 1997-12-03 | 2003-11-04 | Genentech, Inc. | Secreted polypeptides that stimulate release of proteoglycans from cartilage |
FR2767135B1 (fr) | 1997-08-06 | 2002-07-12 | Genset Sa | Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes |
US20020132981A1 (en) * | 1997-12-03 | 2002-09-19 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
EP1056846A1 (en) * | 1998-02-23 | 2000-12-06 | Smithkline Beecham Plc | Cerebellin-2 related polypeptides and dna coding therefor |
US6406884B1 (en) * | 1999-06-18 | 2002-06-18 | Millennium Pharmaceuticals, Inc. | Secreted proteins and uses thereof |
CA2348828C (en) * | 1998-11-04 | 2009-09-15 | Genset S.A. | Genomic and complete cdna sequences of apm1 and biallelic markers thereof |
CA2359757A1 (en) | 1999-02-10 | 2000-08-17 | Genset S.A. | Polymorphic markers of the lsr gene |
US6544946B1 (en) | 1999-02-19 | 2003-04-08 | Zymogenetics, Inc. | Inhibitors for use in hemostasis and immune function |
KR20010102130A (ko) | 1999-02-19 | 2001-11-15 | 리스 데브라 케이. | 지혈 및 면역기능에 사용하기 위한 억제제 |
US20050042719A1 (en) * | 1999-05-27 | 2005-02-24 | Zymogenetics, Inc. | Adipocyte complement related protein homolog zacrp5 |
JP2003501028A (ja) * | 1999-05-27 | 2003-01-14 | ザイモジェネティクス,インコーポレイティド | 脂肪細胞補体関連タンパク質同族体zacrp7 |
WO2001032868A1 (en) * | 1999-11-04 | 2001-05-10 | Genset | Apm1 biallelic markers and uses thereof |
US6566332B2 (en) * | 2000-01-14 | 2003-05-20 | Genset S.A. | OBG3 globular head and uses thereof for decreasing body mass |
US7338787B2 (en) * | 2000-01-14 | 2008-03-04 | Serono Genetics Institute S.A. | Nucleic acids encoding OBG3 globular head and uses thereof |
US6989367B2 (en) | 2000-01-14 | 2006-01-24 | Genset S.A. | OBG3 globular head and uses thereof |
US20020058617A1 (en) * | 2000-01-14 | 2002-05-16 | Joachim Fruebis | OBG3 globular head and uses thereof for decreasing body mass |
US6579852B2 (en) * | 2000-01-14 | 2003-06-17 | Genset S.A. | OBG3 globular head and uses thereof for decreasing body mass |
CA2433841A1 (en) * | 2001-01-16 | 2002-08-29 | Mary Ruth Erickson | Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
EP1422241A1 (en) | 2002-11-19 | 2004-05-26 | Alexander Steinkasserer | Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
US9102726B2 (en) * | 2002-12-04 | 2015-08-11 | Argos Therapeutics, Inc. | Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same |
US7169898B2 (en) | 2002-12-04 | 2007-01-30 | Alexander Steinkasserer | Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells |
US20110182903A1 (en) * | 2008-05-23 | 2011-07-28 | Stephen Brand | Novel soluble cd83 polypeptides, formulations and methods of use |
CN102940875B (zh) * | 2012-10-31 | 2015-09-30 | 中国人民解放军军事医学科学院微生物流行病研究所 | Paa蛋白及由其制备的抗体与应用 |
FI3019240T3 (fi) | 2013-07-09 | 2024-05-30 | Annexon Inc | Anti-komplementtitekijä c1q -vasta-aineita ja niiden käyttöjä |
JP6951246B2 (ja) | 2014-11-05 | 2021-10-20 | アネクソン,インコーポレーテッド | ヒト化抗補体因子C1q抗体及びその使用 |
IL296130A (en) | 2015-11-24 | 2022-11-01 | Annexon Inc | Anti-complement factor c1q fab fragments and their uses |
CN110195070B (zh) * | 2019-05-31 | 2022-11-04 | 天津大学 | 大肠杆菌全局调控因子的突变基因crp及应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869330A (en) | 1995-06-05 | 1999-02-09 | Whitehead Institute For Biomedical Research | DNA encoding a novel serum protein produced exclusively in adipocytes |
WO2000032778A2 (en) | 1998-12-01 | 2000-06-08 | Genentech, Inc. | Methods and compositions for inhibiting neoplastic cell growth |
NZ504548A (en) | 1997-12-03 | 2003-06-30 | Genentech Inc | Polypeptides and nucleic acids encoding human chordin |
AU2212299A (en) | 1998-01-05 | 1999-07-26 | Genentech Inc. | Compositions and methods for the treatment of tumor |
US6406884B1 (en) | 1999-06-18 | 2002-06-18 | Millennium Pharmaceuticals, Inc. | Secreted proteins and uses thereof |
KR20010102960A (ko) | 1998-12-22 | 2001-11-17 | 제넨테크, 인크. | 종양 치료용 조성물 및 방법 |
JP2004516227A (ja) | 1999-03-08 | 2004-06-03 | ジェネンテック・インコーポレーテッド | 免疫関連疾患を治療するための組成物と方法 |
-
1998
- 1998-08-26 DE DE69834334T patent/DE69834334T2/de not_active Expired - Fee Related
- 1998-08-26 AU AU90362/98A patent/AU744254B2/en not_active Ceased
- 1998-08-26 JP JP2000507800A patent/JP3492999B2/ja not_active Expired - Fee Related
- 1998-08-26 WO PCT/US1998/017724 patent/WO1999010492A1/en active IP Right Grant
- 1998-08-26 AT AT98942266T patent/ATE324443T1/de not_active IP Right Cessation
- 1998-08-26 EP EP98942266A patent/EP1009829B1/en not_active Expired - Lifetime
- 1998-08-26 CA CA002301660A patent/CA2301660A1/en not_active Abandoned
- 1998-08-26 CN CN98809769A patent/CN1272884A/zh active Pending
- 1998-08-26 US US09/140,804 patent/US6197930B1/en not_active Expired - Lifetime
- 1998-08-26 KR KR1020007001961A patent/KR20010023325A/ko not_active Application Discontinuation
-
2000
- 2000-02-25 NO NO20000934A patent/NO20000934L/no not_active Application Discontinuation
- 2000-10-10 US US09/686,838 patent/US6482612B1/en not_active Expired - Fee Related
-
2002
- 2002-07-16 US US10/197,293 patent/US20030171547A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030171547A1 (en) | 2003-09-11 |
ATE324443T1 (de) | 2006-05-15 |
DE69834334D1 (de) | 2006-06-01 |
US6482612B1 (en) | 2002-11-19 |
DE69834334T2 (de) | 2007-04-26 |
JP3492999B2 (ja) | 2004-02-03 |
CA2301660A1 (en) | 1999-03-04 |
US6197930B1 (en) | 2001-03-06 |
NO20000934L (no) | 2000-04-26 |
WO1999010492A1 (en) | 1999-03-04 |
JP2001513998A (ja) | 2001-09-11 |
AU744254B2 (en) | 2002-02-21 |
KR20010023325A (ko) | 2001-03-26 |
AU9036298A (en) | 1999-03-16 |
EP1009829B1 (en) | 2006-04-26 |
CN1272884A (zh) | 2000-11-08 |
EP1009829A1 (en) | 2000-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20000934D0 (no) | Adipocyttspesifikke proteinhomologer | |
DK1002075T3 (da) | Adipocyt-specifikke proteinhomologer | |
EA200001023A1 (ru) | Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью | |
EA200000216A1 (ru) | Белки, связывающие интерлейкин-18, их получение и применение | |
NZ504114A (en) | Vitamin k-dependent polypeptides such as protein C where substitution at amino acid sites 11, 12, 29, 33 or 34 affects membrane binding affinity of the protein and ultimately blood clotting ability | |
NZ330897A (en) | Human trk receptors and neurotropic factor inhibitors | |
ATE349700T1 (de) | Übergangsmetallkomplex-haltige lumineszente proteinfarben | |
DE50012863D1 (de) | Strukturprotein von adeno-assoziiertem virus mit veränderten chromatographischen eigenschaften | |
ATE229542T1 (de) | Fusionspolypeptid zur beeinflussung von wechselwirkungen zwischen proteinen | |
ATE335818T1 (de) | Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung | |
BR9509172A (pt) | Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica | |
DE69531958D1 (de) | (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper | |
ATE355302T1 (de) | N-substituierte d-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation | |
NO922421D0 (no) | Collagenbindende protein, samt fremstilling derav | |
DE69831084D1 (de) | Beta-defensine | |
DK0968288T3 (da) | z219a, en human homolog til 2-19 protein | |
PT723552E (pt) | Oligopeptidos derivados de fragmentos de proteina reactiva c | |
WO2002059282A3 (en) | Adipocyte complement related protein zacrp13 | |
WO2000073446A3 (en) | Adipocyte complement related protein homolog zacrp6 | |
NO20015114L (no) | Adipocyttkomplementbeslektet proteinhomolog zacrp2 | |
ATE343794T1 (de) | Ph-abhängige polypeptidaggregation und verwendung davon | |
DE69033553D1 (de) | Rekombinante herstellung von laktoperoxidase | |
WO2002044373A3 (en) | Adipocyte complement related protein zacrp12 | |
EA199900663A1 (ru) | Новые белки, связывающиеся с рецептором 1 интерферона, кодирующая их днк и способы модуляции клеточного ответа на интерфероны | |
WO2002070704A3 (en) | Adipocyte complement related protein zacrp11 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |